Medicare Enrolled

Dr. Kay Kyaw, M.D.

Optician · Montebello, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3114 W BEVERLY BLVD, Montebello, CA 90640
3237263868
In practice since 2010 (15 years)
NPI: 1912223850 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kyaw from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kyaw? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kyaw

Dr. Kay Kyaw is an optician specialist in Montebello, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Kyaw performed 1,770 Medicare services across 803 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kyaw received a total of $7,681 from 23 pharmaceutical and/or device companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kyaw is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 40% volume in CA $7,681 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,770
Medicare services
Top 40% in CA for optician
803
Unique beneficiaries
$141
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
920 $101 $248
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
222 $141 $362
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
217 $294 $742
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
184 $180 $582
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
111 $81 $274
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
56 $247 $618
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
41 $108 $384
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
19 $68 $164
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,681
Total received (2018-2024)
Avg $1,097/year across 7 years
Top 17% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
357
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,681 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,779
2023
$1,500
2022
$2,015
2021
$1,364
2020
$248
2019
$585
2018
$190

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$453
Fresenius USA Marketing, Inc.
$272
Travere Therapeutics, Inc.
$210
AstraZeneca Pharmaceuticals LP
$159
Vifor Pharma, Inc.
$140
Bayer Healthcare Pharmaceuticals Inc.
$100
CALLIDITAS THERAPEUTICS US INC.
$80
Novo Nordisk Inc
$75
Ardelyx, Inc.
$57
AKEBIA THERAPEUTICS INC
$54
OPKO Pharmaceuticals, LLC
$44
GlaxoSmithKline, LLC.
$35
Mallinckrodt Hospital Products Inc.
$28
ANI Pharmaceuticals, Inc.
$27
Otsuka America Pharmaceutical, Inc.
$26
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,068
Fresenius USA Marketing, Inc.
$980
AstraZeneca Pharmaceuticals LP
$867
AKEBIA THERAPEUTICS INC
$618
GlaxoSmithKline, LLC.
$605
Horizon Therapeutics plc
$604
Bayer HealthCare Pharmaceuticals Inc.
$467
Otsuka America Pharmaceutical, Inc.
$428
Vifor Pharma, Inc.
$276
Travere Therapeutics, Inc.
$253
CALLIDITAS THERAPEUTICS US INC.
$194
Aurinia Pharma U.S., Inc.
$190
Novo Nordisk Inc
$167
Relypsa, Inc.
$155
OPKO Pharmaceuticals, LLC
$121
Bayer Healthcare Pharmaceuticals Inc.
$121
Mallinckrodt Hospital Products Inc.
$119
Calliditas Therapeutics US Inc.
$113
Baxter Healthcare
$96
BAXTER HEALTHCARE
$81
Ardelyx, Inc.
$76
ANI Pharmaceuticals, Inc.
$47
Novartis Pharmaceuticals Corporation
$33
Top 3 companies account for 38.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Aranesp · Auryxia · BENLYSTA · EPOGEN · FARXIGA · IBSRELA · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Renal - Extraneal Solution · Renal - Non Product Related · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · Vafseo · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Montebello?
Compare opticians in the Montebello area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
1,792
Per 100K population
18.2
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL MONTEBELLO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kyaw is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of CA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kyaw experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Kyaw performed 920 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kyaw receive payments from pharmaceutical companies?
Yes. Dr. Kyaw received a total of $7,681 from 23 companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kyaw's costs compare to other opticians in Montebello?
Dr. Kyaw's average Medicare payment per service is $141. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kyaw) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →